• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2疾病图谱的机制建模。

Mechanistic modeling of the SARS-CoV-2 disease map.

作者信息

Rian Kinza, Esteban-Medina Marina, Hidalgo Marta R, Çubuk Cankut, Falco Matias M, Loucera Carlos, Gunyel Devrim, Ostaszewski Marek, Peña-Chilet María, Dopazo Joaquín

机构信息

Bioinformatics Area, Fundación Progreso y Salud (FPS), Hospital Virgen del Rocío, Sevilla, Spain.

Computational Systems Medicine, Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocio, 41013, Sevilla, Spain.

出版信息

BioData Min. 2021 Jan 21;14(1):5. doi: 10.1186/s13040-021-00234-1.

DOI:10.1186/s13040-021-00234-1
PMID:33478554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7817765/
Abstract

Here we present a web interface that implements a comprehensive mechanistic model of the SARS-CoV-2 disease map. In this framework, the detailed activity of the human signaling circuits related to the viral infection, covering from the entry and replication mechanisms to the downstream consequences as inflammation and antigenic response, can be inferred from gene expression experiments. Moreover, the effect of potential interventions, such as knock-downs, or drug effects (currently the system models the effect of more than 8000 DrugBank drugs) can be studied. This freely available tool not only provides an unprecedentedly detailed view of the mechanisms of viral invasion and the consequences in the cell but has also the potential of becoming an invaluable asset in the search for efficient antiviral treatments.

摘要

在此,我们展示了一个网络界面,该界面实现了新冠病毒疾病图谱的综合机制模型。在此框架下,与病毒感染相关的人类信号通路的详细活动,从病毒进入和复制机制到炎症和抗原反应等下游后果,都可以从基因表达实验中推断出来。此外,还可以研究潜在干预措施的效果,如基因敲除或药物作用(目前该系统模拟了8000多种药物银行药物的作用)。这个免费工具不仅提供了关于病毒入侵机制及其在细胞内后果的前所未有的详细视图,而且在寻找有效的抗病毒治疗方法方面也有可能成为一项宝贵资产。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aae/7819249/1658562c4a8e/13040_2021_234_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aae/7819249/1658562c4a8e/13040_2021_234_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0aae/7819249/1658562c4a8e/13040_2021_234_Fig1_HTML.jpg

相似文献

1
Mechanistic modeling of the SARS-CoV-2 disease map.严重急性呼吸综合征冠状病毒2疾病图谱的机制建模。
BioData Min. 2021 Jan 21;14(1):5. doi: 10.1186/s13040-021-00234-1.
2
Therapeutic potential of green tea catechin, (-)-epigallocatechin-3--gallate (EGCG) in SARS-CoV-2 infection: Major interactions with host/virus proteases.绿茶儿茶素(-)-表没食子儿茶素-3-没食子酸酯(EGCG)在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染中的治疗潜力:与宿主/病毒蛋白酶的主要相互作用
Phytomed Plus. 2023 Feb;3(1):100402. doi: 10.1016/j.phyplu.2022.100402. Epub 2022 Dec 30.
3
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.SARS-CoV-2 及其他人类致病冠状病毒的抗病毒药物和可用药靶的现状。
Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26.
4
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.
5
Current Strategies of Antiviral Drug Discovery for COVID-19.新型冠状病毒肺炎抗病毒药物研发的当前策略
Front Mol Biosci. 2021 May 13;8:671263. doi: 10.3389/fmolb.2021.671263. eCollection 2021.
6
Identification of oral therapeutics using an AI platform against the virus responsible for COVID-19, SARS-CoV-2.使用人工智能平台鉴定针对导致COVID-19的病毒——严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的口服治疗药物。
Front Pharmacol. 2023 Dec 22;14:1297924. doi: 10.3389/fphar.2023.1297924. eCollection 2023.
7
A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm.涉及 RAS 介导的缓激肽风暴的 COVID-19 的机械模型和治疗干预。
Elife. 2020 Jul 7;9:e59177. doi: 10.7554/eLife.59177.
8
Hippo signaling pathway activation during SARS-CoV-2 infection contributes to host antiviral response.SARS-CoV-2 感染期间 Hippo 信号通路的激活有助于宿主抗病毒反应。
PLoS Biol. 2022 Nov 8;20(11):e3001851. doi: 10.1371/journal.pbio.3001851. eCollection 2022 Nov.
9
Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection.利用慢病毒 hACE2 载体在小鼠中模拟 SARS-CoV-2 感染,推断出两种针对 SARS-CoV-2 感染的免疫反应模式。
Viruses. 2021 Dec 21;14(1):11. doi: 10.3390/v14010011.
10
The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.SARS-CoV-2 利用血管紧张素转换酶 2 进入细胞进行复制的机制概述:与肾素-血管紧张素系统相关的可能治疗选择。
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):317-325. doi: 10.1093/ehjcvp/pvaa053.

引用本文的文献

1
Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches.利用计算系统生物学方法鉴定 COVID-19 疾病机制中的药物靶点。
Front Immunol. 2024 Feb 13;14:1282859. doi: 10.3389/fimmu.2023.1282859. eCollection 2023.
2
COVID infection in 4 steps: Thermodynamic considerations reveal how viral mucosal diffusion, target receptor affinity and furin cleavage act in concert to drive the nature and degree of infection in human COVID-19 disease.新冠病毒感染的四个步骤:热力学考量揭示了病毒黏膜扩散、靶受体亲和力和弗林蛋白酶切割如何协同作用,以驱动人类新冠疾病感染的性质和程度。
Heliyon. 2023 Jun;9(6):e17174. doi: 10.1016/j.heliyon.2023.e17174. Epub 2023 Jun 12.
3

本文引用的文献

1
Mechanistic models of signaling pathways deconvolute the glioblastoma single-cell functional landscape.信号通路的机制模型解析了胶质母细胞瘤单细胞功能图谱。
NAR Cancer. 2020 Jun 25;2(2):zcaa011. doi: 10.1093/narcan/zcaa011. eCollection 2020 Jun.
2
Web tools to fight pandemics: the COVID-19 experience.网络工具抗击大流行:COVID-19 疫情的经验。
Brief Bioinform. 2021 Mar 22;22(2):690-700. doi: 10.1093/bib/bbaa261.
3
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.宿主对 SARS-CoV-2 的失衡反应导致 COVID-19 的发生。
Discovering potential interactions between rare diseases and COVID-19 by combining mechanistic models of viral infection with statistical modeling.
通过将病毒感染的机制模型与统计建模相结合,发现罕见病与 COVID-19 之间的潜在相互作用。
Hum Mol Genet. 2022 Jun 22;31(12):2078-2089. doi: 10.1093/hmg/ddac007.
4
VDA-RWLRLS: An anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares.VDA-RWLRLS:一种结合非平衡双向随机游走和拉普拉斯正则化最小二乘法的抗SARS-CoV-2药物优先级框架。
Comput Biol Med. 2022 Jan;140:105119. doi: 10.1016/j.compbiomed.2021.105119. Epub 2021 Dec 7.
5
Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients.真实世界证据表明,住院的安达卢西亚患者队列中使用 calcifediol 或维生素 D 处方与 COVID-19 死亡率之间的关系。
Sci Rep. 2021 Dec 3;11(1):23380. doi: 10.1038/s41598-021-02701-5.
6
COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms.COVID19 疾病图谱,一个病毒 - 宿主相互作用机制的计算知识库。
Mol Syst Biol. 2021 Oct;17(10):e10387. doi: 10.15252/msb.202110387.
7
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients.NF-κB 通路作为治疗危重症 COVID-19 患者的潜在靶点。
Front Immunol. 2020 Dec 10;11:598444. doi: 10.3389/fimmu.2020.598444. eCollection 2020.
8
CovMulNet19, Integrating Proteins, Diseases, Drugs, and Symptoms: A Network Medicine Approach to COVID-19.CovMulNet19:整合蛋白质、疾病、药物和症状——一种针对新冠肺炎的网络医学方法
Netw Syst Med. 2020 Nov 17;3(1):130-141. doi: 10.1089/nsm.2020.0011. eCollection 2020.
Cell. 2020 May 28;181(5):1036-1045.e9. doi: 10.1016/j.cell.2020.04.026. Epub 2020 May 15.
4
COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms.COVID-19 疾病图谱,构建 SARS-CoV-2 病毒-宿主相互作用机制的计算知识库。
Sci Data. 2020 May 5;7(1):136. doi: 10.1038/s41597-020-0477-8.
5
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.一种 SARS-CoV-2 蛋白相互作用图谱揭示了药物再利用的靶标。
Nature. 2020 Jul;583(7816):459-468. doi: 10.1038/s41586-020-2286-9. Epub 2020 Apr 30.
6
Applications of personalised signalling network models in precision oncology.个性化信号网络模型在精准肿瘤学中的应用。
Pharmacol Ther. 2020 Aug;212:107555. doi: 10.1016/j.pharmthera.2020.107555. Epub 2020 Apr 19.
7
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.基于网络的2019新型冠状病毒(2019-nCoV/SARS-CoV-2)药物重新利用研究
Cell Discov. 2020 Mar 16;6:14. doi: 10.1038/s41421-020-0153-3. eCollection 2020.
8
Personalized signaling models for personalized treatments.个性化信号模型用于个性化治疗。
Mol Syst Biol. 2020 Jan;16(1):e9042. doi: 10.15252/msb.20199042.
9
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.突破:磷酸氯喹在临床研究中显示出对 COVID-19 相关肺炎的明显疗效。
Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
10
A novel coronavirus outbreak of global health concern.一场引发全球卫生关注的新型冠状病毒疫情。
Lancet. 2020 Feb 15;395(10223):470-473. doi: 10.1016/S0140-6736(20)30185-9. Epub 2020 Jan 24.